GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Company Overview - Glucotrack, Inc. is a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes [4][5] - The company is currently developing a long-term implantable continuous blood glucose monitoring system with a sensor longevity of over 2 years, minimal calibration, and no on-body wearable component [1][5] Upcoming Events - Paul V. Goode, CEO of Glucotrack, will present at the Sidoti Small Cap Investor Conference on June 12, 2024, at 3:15 PM ET and will hold one-on-one meetings [1][4] - Interested parties can register for the event through a provided webcast link [1] Product Details - Glucotrack's continuous blood glucose monitoring (CBGM) system is designed for long-term use, targeting individuals living with diabetes [5] - The system aims to provide a more convenient and less intrusive method for monitoring blood glucose levels compared to traditional methods [5]